cagrisema cagrilintide semaglutide phase 3 obesity drug: what the data shows The next frontier in metabolic

In recent months, access to GLP-1 medications for weight management has been dealt a major setback, with insurers like Blue Cross Blue Shield announcing they will drop coverage for anti-obesity drugs in Massachusetts

This is because semaglutide is metabolized and excreted through the kidneys, producing metabolites that drug tests are not designed to detect

Its such a hot topic these days that I couldnt resist talking about some of the key factors when it comes to diet and GLP-1 medications

Semaglutide is a powerful medication with far-reaching effects on the body

Ferroptosis, a new form of cell death, and its relationships with tumourous diseases